H

Hindustan Bio Sciences Limited

HINDBIO
Market snapshot · 2026-08-11 04:01 UTC

6.60

₹-0.01 (-0.15%)

MARKET CAP

₹6.77 Cr

STOCK P/E

52W HIGH

₹9.92

52W LOW

₹5.00

BOOK VALUE

₹0.78

EPS

₹-0.20

ROE

SECTOR

Health Care

DEBT/EQUITY

284.44

VOLUME

20,267

P/B RATIO

8.47x

PEG RATIO

Sector

Health Care

Themes

Biotechnology
₹9.43₹8.36₹7.28₹6.21₹5.13VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Hindustan Bio Sciences Limited is a company with no disclosed operating sector or business segments. Its filings provide no specific products, platforms, or revenue drivers, limiting assessment of business composition and operating catalysts. No major recent developments have been reported. Margins are described as stable, but ROE, leverage, revenue growth, and profit growth are unavailable, preventing meaningful earnings-quality analysis. P/E is also unavailable, so valuation cannot be classified as fair, rich, or discounted. Neutral sentiment reflects limited disclosure rather than a clear operating outlook.

Valuation Metrics

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/S
Undervalued

5Y Average

17.45

Current

16.85

Overvalued

21.77

Undervalued

12.98

P/B
Strongly Undervalued

5Y Average

9.25

Current

8.49

Overvalued

10.42

Undervalued

8.84

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹0.00 CrJun 2026

Latest net profit

₹-0.11 CrJun 2026

Latest EPS

₹-0.11Jun 2026

Free cash flow

₹0.27 CrMar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q1 '26Q2 '26Q3 '26Q4 '26Q1 '270.0%5.0%10.0%15.0%20.0%-0.15 Cr0.00 Cr0.15 Cr0.30 Cr0.45 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q1 '26Q2 '26Q3 '26Q4 '26Q1 '270.00 Cr0.10 Cr0.19 Cr0.28 Cr0.38 Cr₹-0₹-0₹0₹0₹0
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOperatingprofitOther incomeInterestProfitbefore taxTax & otherNet Profit-0.12 Cr-0.09 Cr-0.06 Cr-0.03 Cr0.00 Cr

Latest reported period: Jun 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-2.00 Cr0.00 Cr2.00 Cr4.00 Cr6.00 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales +0.000.320.320.390.410.410.000.380.320.000.380.000.00
Expenses +0.120.260.260.350.340.340.040.280.320.060.310.110.11
Operating Profit-0.120.060.060.040.070.07-0.040.100.00-0.060.07-0.11-0.11
OPM %18.75%18.75%10.26%17.07%17.07%26.32%0.00%18.42%
Other Income +0.000.010.010.000.010.010.000.010.010.010.020.000.00
Interest0.000.000.000.000.000.000.000.000.000.000.000.000.00
Depreciation0.000.000.000.000.000.000.000.000.000.000.010.000.00
Profit before tax-0.120.070.070.040.080.08-0.040.110.01-0.050.08-0.11-0.11
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit +-0.120.070.070.040.080.08-0.040.110.01-0.060.08-0.12-0.11
EPS in Rs-0.120.070.070.040.080.08-0.040.110.01-0.060.08-0.12-0.11
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters +12.19%12.19%12.19%12.19%12.19%
Public +87.81%87.81%87.81%87.80%87.81%
Others0.01%
Jun 2026
Promoters +
Public +

Events Timeline

Announcement under Regulation 30 (LODR)-Newspaper Publication

Aug 03, 2026PDFCompany Reports Open

Results For The Quarter Ended 30Th June 2026

Jul 31, 2026PDFCompany Reports Open

Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday, July 31 2026 As Required Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation 2015

Jul 31, 2026PDFCompany Reports Open

Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 (1) (A) Of SEBI (LODR) Regulations, 2015

Jul 22, 2026PDFCompany Reports Open

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Jul 09, 2026PDFCompany Reports Open